We provide you with 20 years of free, institutional-grade data for ARWR stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ARWR. Explore the full financial landscape of ARWR stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$1,025,000
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Hamilton James C | Sale | -15,000 | $30 | $450,000 | 2025-09-16 |
| Hamilton James C | Sale | -15,000 | $25 | $375,000 | 2025-09-04 |
| Hamilton James C | Sale | -10,000 | $20 | $200,000 | 2025-08-15 |
| Apel Daniel Joseph | Initial | 2025-08-12 | |||
| Anzalone Christopher Richard | Sale | -141,122 | $9.93 | $1,401,341 | 2025-04-11 |
| Anzalone Christopher Richard | Sale | -51,425 | $15.07 | $774,975 | 2025-03-17 |
| Anzalone Christopher Richard | Grant, award...etc | 340,000 | 2025-03-17 | ||
| Anzalone Christopher Richard | Sale | -300,000 | $18.03 | $5,409,000 | 2025-03-05 |
| Anzalone Christopher Richard | Derivatives Exercise | 0 | 2025-03-05 | ||
| Anzalone Christopher Richard | Grant, award...etc | 9,550 | $20.1 | 2025-02-10 | |
| INGRAM DOUGLAS S | Grant, award...etc | 38,396 | $20.09 | 2025-02-07 | |
| OLUKOTUN ADEOYE Y | Sale | -959 | $21 | $20,139 | 2025-01-27 |
| O'Brien Patrick | Sale | -37,184 | $19.69 | $732,153 | 2025-01-07 |
| O'Brien Patrick | Grant, award...etc | 100,000 | 2025-01-07 | ||
| Hamilton James C | Sale | -32,729 | $19.68 | $644,107 | 2025-01-07 |
| Hamilton James C | Grant, award...etc | 100,000 | 2025-01-07 | ||
| Myszkowski Kenneth Allen | Sale | -45,167 | $19.68 | $888,887 | 2025-01-07 |
| Myszkowski Kenneth Allen | Grant, award...etc | 100,000 | 2025-01-07 | ||
| Anzalone Christopher Richard | Sale | -11,520 | $19.05 | $219,456 | 2025-01-06 |
| OLUKOTUN ADEOYE Y | Sale | -2,850 | $20 | $57,000 | 2024-12-30 |
| Anzalone Christopher Richard | Sale | -12,563 | $19.59 | $246,109 | 2024-12-23 |
| Waddill William D. | Grant, award...etc | 16,733 | $22.99 | 2024-12-20 | |
| Ferrari Mauro | Grant, award...etc | 16,733 | $22.99 | 2024-12-20 | |
| Lu Hongbo | Grant, award...etc | 16,733 | $22.99 | 2024-12-20 | |
| PERRY MICHAEL S | Grant, award...etc | 16,733 | $22.99 | 2024-12-20 | |
| Anzalone Christopher Richard | Grant, award...etc | 100,000 | 2024-12-20 | ||
| Anzalone Christopher Richard | Sale | -26,712 | $20.52 | $548,130 | 2024-12-20 |
| OLUKOTUN ADEOYE Y | Grant, award...etc | 16,733 | $22.99 | 2024-12-20 | |
| Vakiener Victoria | Grant, award...etc | 16,733 | $22.99 | 2024-12-20 | |
| Waddill William D. | Sale | -7,495 | $21.9 | $164,141 | 2024-12-18 |
| Vakiener Victoria | Sale | -8,994 | $21.91 | $197,059 | 2024-12-18 |
| GIVEN DOUGLAS B | Sale | -5,547 | $21.9 | $121,479 | 2024-12-18 |
| Oliver Tracie | Sale | -9,394 | $25.28 | $237,480 | 2024-07-03 |
| Vakiener Victoria | Sale | -1,799 | $23.31 | $41,935 | 2024-05-06 |
| Hamilton James C | Sale | -6,000 | $28.03 | $168,180 | 2024-04-03 |
| Lu Hongbo | Open Market Purchase | 3,000 | $27.49 | 2024-03-20 | |
| Lu Hongbo | Initial | 2024-03-18 | |||
| Myszkowski Kenneth Allen | Sale | -40,000 | $35.19 | $1,407,600 | 2024-03-08 |
| Anzalone Christopher Richard | Sale | -57,499 | $32.16 | $1,849,168 | 2024-02-02 |
| Anzalone Christopher Richard | Derivatives Exercise | 57,499 | 2024-02-02 | ||
| Hamilton James C | Sale | -7,940 | $36.47 | $289,572 | 2024-01-17 |
| Vakiener Victoria | Sale | -4,720 | $37.87 | $178,746 | 2024-01-16 |
| Ferrari Mauro | Sale | -3,147 | $37.8 | $118,957 | 2024-01-16 |
| GIVEN DOUGLAS B | Sale | -2,911 | $37.76 | $109,919 | 2024-01-16 |
| Waddill William D. | Sale | -3,934 | $37.81 | $148,745 | 2024-01-16 |
| Oliver Tracie | Sale | -74 | $33.89 | $2,508 | 2024-01-08 |
| Oliver Tracie | Grant, award...etc | 75,000 | 2024-01-08 | ||
| San Martin Javier | Sale | -8,303 | $34.11 | $283,215 | 2024-01-08 |
| San Martin Javier | Grant, award...etc | 75,000 | 2024-01-08 | ||
| Myszkowski Kenneth Allen | Sale | -16,104 | $34.04 | $548,180 | 2024-01-08 |
| Myszkowski Kenneth Allen | Grant, award...etc | 75,000 | 2024-01-08 | ||
| O'Brien Patrick | Grant, award...etc | 85,000 | 2024-01-05 | ||
| O'Brien Patrick | Sale | -33,190 | $31.83 | $1,056,438 | 2024-01-05 |
| Hamilton James C | Grant, award...etc | 75,000 | 2024-01-05 | ||
| Hamilton James C | Sale | -38,443 | $31.81 | $1,222,872 | 2024-01-05 |
| Anzalone Christopher Richard | Sale | -9,952 | $30.74 | $305,924 | 2024-01-04 |
| Anzalone Christopher Richard | Sale | -12,000 | $28.54 | $342,480 | 2023-12-22 |
| OLUKOTUN ADEOYE Y | Grant, award...etc | 14,987 | $25.41 | 2023-12-19 | |
| Waddill William D. | Grant, award...etc | 14,987 | $25.41 | 2023-12-19 | |
| Vakiener Victoria | Grant, award...etc | 14,987 | $25.41 | 2023-12-19 | |
| GIVEN DOUGLAS B | Grant, award...etc | 14,987 | $25.41 | 2023-12-19 | |
| Ferrari Mauro | Grant, award...etc | 14,987 | $25.41 | 2023-12-19 | |
| PERRY MICHAEL S | Grant, award...etc | 14,987 | $25.41 | 2023-12-19 | |
| San Martin Javier | Sale | -19,700 | $28.73 | $565,981 | 2023-11-22 |
| Anzalone Christopher Richard | Sale | -24,338 | $24.21 | $589,223 | 2023-10-27 |
| Vakiener Victoria | Sale | -1,550 | $26.33 | $40,812 | 2023-10-02 |
| Anzalone Christopher Richard | Sale | -57,755 | $28 | $1,617,140 | 2023-09-20 |
| Anzalone Christopher Richard | Derivatives Exercise | 57,755 | 2023-09-20 | ||
| Oliver Tracie | Sale | -8,925 | $35.31 | $315,142 | 2023-07-06 |
| Hamilton James C | Sale | -3,000 | $35.53 | $106,590 | 2023-07-05 |
| Myszkowski Kenneth Allen | Sale | -15,000 | $36.2 | $543,000 | 2023-06-29 |
| GIVEN DOUGLAS B | Sale | -6,500 | $40.9 | $265,850 | 2023-05-08 |
| Anzalone Christopher Richard | Sale | -104,928 | $39.14 | $4,106,882 | 2023-05-05 |
| Anzalone Christopher Richard | Derivatives Exercise | 104,928 | 2023-05-05 | ||
| OLUKOTUN ADEOYE Y | Sale | -11,350 | $32.65 | $370,578 | 2023-03-06 |
| GIVEN DOUGLAS B | Sale | -875 | $32.62 | $28,542 | 2023-03-01 |
The information provided in this report about ARWR stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Arrowhead Pharmaceuticals, Inc(NASDAQ:ARWR) 
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated wi...
Website: http://arrowheadpharma.com
Founded: 1989
Full Time Employees: 232
Sector: Healthcare
Industry: Biotechnology